Short communication · 28 Mar 2022
Byline
A. Abotaleb
Articles whose byline reads A. Abotaleb, printed as Abdalla Abotaleb and Ahmed Abotaleb. Different authors can share a byline.
- Articles
- 19
- Latest year
- 2022
Articles
Newest first. Showing 1–19 of 19 articles.
Conference abstract · 4 Jan 2021
Innovative medicines & oncology practice during covid.
Conference abstract · 4 Jan 2021
Editorial note on 2nd Global Meeting on Oncology and Radiology December 10, 2020 Webinar
Short communication · 29 Aug 2020
Impact of innovative treatments on economic burden of hepatocellular carcinoma at low middle- income countries
Short communication · 20 Jul 2020
The Impact of Innovative Treatments on the Economic Burden of Hepatocellular Carcinoma at Low Middle Income Countries
Conference abstract · 29 Jun 2020
Impact of innovative treatments on economic burden of hepatocellular carcinoma At low middle income countries
Editorial · 2 May 2020
Oncology 2020 conference scheduled at Paris, France during February 20-21, 2020
Conference proceeding · 2020
Effect of data selection on reimbursement decisions: Breast Cancer Case
Other · 2019
Awards for Clinical Oncology and Radiation Therapy Conference, October 19-20, 2020 at Singapore
Conference abstract · 2019
Cancer Research 2018: Cost effectiveness analysis of Cetuximab treatment of locally advanced head and neck cancer - Abdalla Abotaleb - World Health Organization, Egypt
Other · 2019
Oncology 2020 congress scheduled during February 20-21, 2020 | Paris, Francezation (WHO), Egypt
Market analysis · 2019
Market Report on Oncology | Oncology 2020 is going to be held on February 20-21, 2020 in Paris, France
Article · 2019
Oncology 2020 congress scheduled during February 20-21, 2020 | Paris, Francezation (WHO), Egypt
Article · 2019
Market Report on Oncology | Oncology 2020 is going to be held on February 20-21, 2020 in Paris, France
Conference abstract · 3 Sep 2018
Impact of sequencing of treatment lines to enhance patient’s outcomes & resource utilization for metastatic breast cancer
Conference abstract · 3 Sep 2018
Why oncology field need Biosimilars?
Conference abstract · 2018
Impact of Bortezomib versus VAD as induction therapy for enhancing patients outcomes and resources utilization for low middle income countries with multiple myeloma patients
Conference abstract · 2018
Cost effectiveness analysis of Cetuximab treatment of locally advanced head and neck cancer
Research article · 2017
